These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15681320)

  • 1. Comparison of the hepatic perfusion index measured with gadolinium-enhanced volumetric MRI in controls and in patients with colorectal cancer.
    Totman JJ; O'gorman RL; Kane PA; Karani JB
    Br J Radiol; 2005 Feb; 78(926):105-9. PubMed ID: 15681320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parametric mapping of the hepatic perfusion index with gadolinium-enhanced volumetric MRI.
    White MJ; O'Gorman RL; Charles-Edwards EM; Kane PA; Karani JB; Leach MO; Totman JJ
    Br J Radiol; 2007 Feb; 80(950):113-20. PubMed ID: 16854961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective assessment of the hepatic perfusion index in patients with colorectal cancer.
    Warren HW; Gallagher H; Hemingway DM; Angerson WJ; Bessent RG; Wotherspoon H; McArdle CS; Cooke TG
    Br J Surg; 1998 Dec; 85(12):1708-12. PubMed ID: 9876080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in hepatic perfusion assessed by dynamic contrast enhanced MRI, associated with morphologic evaluation, in patients with liver metastases from colorectal cancer treated with first-line chemotherapy.
    Tampellini M; Gned D; Baratelli C; Brizzi MP; Ottone A; Alabiso I; Bertaggia C; Di Maio M; Scagliotti GV; Veltri A
    Radiol Med; 2016 Dec; 121(12):950-957. PubMed ID: 27601143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic enhancement in colorectal cancer: texture analysis correlates with hepatic hemodynamics and patient survival.
    Ganeshan B; Miles KA; Young RC; Chatwin CR
    Acad Radiol; 2007 Dec; 14(12):1520-30. PubMed ID: 18035281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of colorectal hepatic metastases: comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI.
    Muhi A; Ichikawa T; Motosugi U; Sou H; Nakajima H; Sano K; Sano M; Kato S; Kitamura T; Fatima Z; Fukushima K; Iino H; Mori Y; Fujii H; Araki T
    J Magn Reson Imaging; 2011 Aug; 34(2):326-35. PubMed ID: 21780227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal cancer: diagnostic potential of CT measurements of hepatic perfusion and implications for contrast enhancement protocols.
    Leggett DA; Kelley BB; Bunce IH; Miles KA
    Radiology; 1997 Dec; 205(3):716-20. PubMed ID: 9393526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3D-liver perfusion MRI with the MS-325 blood pool agent: a noninvasive protocol to asses liver fibrosis.
    Leporq B; Dumortier J; Pilleul F; Beuf O
    J Magn Reson Imaging; 2012 Jun; 35(6):1380-7. PubMed ID: 22281698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incremental value of liver MR imaging in patients with potentially curable colorectal hepatic metastasis detected at CT: a prospective comparison of diffusion-weighted imaging, gadoxetic acid-enhanced MR imaging, and a combination of both MR techniques.
    Kim HJ; Lee SS; Byun JH; Kim JC; Yu CS; Park SH; Kim AY; Ha HK
    Radiology; 2015 Mar; 274(3):712-22. PubMed ID: 25286324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases.
    Seo HJ; Kim MJ; Lee JD; Chung WS; Kim YE
    Invest Radiol; 2011 Sep; 46(9):548-55. PubMed ID: 21577131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Method for quantitation of dynamic MRI contrast agent uptake in colorectal liver metastases.
    van Laarhoven HW; Rijpkema M; Punt CJ; Ruers TJ; Hendriks JC; Barentsz JO; Heerschap A
    J Magn Reson Imaging; 2003 Sep; 18(3):315-20. PubMed ID: 12938126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic transit time analysis using contrast enhanced MRI with Gd-BOPTA: A prospective study comparing patients with liver metastases from colorectal cancer and healthy volunteers.
    Hohmann J; Newerla C; Müller A; Reinicke C; Skrok J; Frericks BB; Albrecht T
    J Magn Reson Imaging; 2012 Dec; 36(6):1389-94. PubMed ID: 22893441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver lesion detection and characterization in patients with colorectal cancer: a comparison of low radiation dose non-enhanced PET/CT, contrast-enhanced PET/CT, and liver MRI.
    Cantwell CP; Setty BN; Holalkere N; Sahani DV; Fischman AJ; Blake MA
    J Comput Assist Tomogr; 2008; 32(5):738-44. PubMed ID: 18830103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of hepatocellular carcinoma and colorectal liver metastasis by means of perfusion MRI.
    Abdullah SS; Pialat JB; Wiart M; Duboeuf F; Mabrut JY; Bancel B; Rode A; Ducerf C; Baulieux J; Berthezene Y
    J Magn Reson Imaging; 2008 Aug; 28(2):390-5. PubMed ID: 18666145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doppler sonographic evaluation of hemodynamic changes in colorectal liver metastases relative to liver size.
    Oktar SO; Yücel C; Demirogullari T; Uner A; Benekli M; Erbas G; Ozdemir H
    J Ultrasound Med; 2006 May; 25(5):575-82. PubMed ID: 16632780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative hepatic CT perfusion measurement: comparison of Couinaud's hepatic segments with dual-source 128-slice CT.
    Wang X; Xue HD; Jin ZY; Su BY; Li Z; Sun H; Chen Y; Liu W
    Eur J Radiol; 2013 Feb; 82(2):220-6. PubMed ID: 23083523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative mapping of hepatic perfusion index using MR imaging: a potential reproducible tool for assessing tumour response to treatment with the antiangiogenic compound BIBF 1120, a potent triple angiokinase inhibitor.
    Miyazaki K; Collins DJ; Walker-Samuel S; Taylor JN; Padhani AR; Leach MO; Koh DM
    Eur Radiol; 2008 Jul; 18(7):1414-21. PubMed ID: 18351351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic perfusion index in the diagnosis of overt metastatic colorectal cancer.
    Ballantyne KC; Charnley RM; Perkins AC; Pye G; Whalley DR; Wastie ML; Hardcastle JD
    Nucl Med Commun; 1990 Jan; 11(1):23-8. PubMed ID: 2338966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perfusion CT and US of colorectal cancer liver metastases: a correlative study of two dynamic imaging modalities.
    Meijerink MR; van Waesberghe JH; van Schaik C; Boven E; van der Veldt AA; van den Tol P; Meijer S; van Kuijk C
    Ultrasound Med Biol; 2010 Oct; 36(10):1626-36. PubMed ID: 20800954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic perfusion changes in patients with liver metastases: comparison with those patients with cirrhosis.
    Leen E; Goldberg JA; Anderson JR; Robertson J; Moule B; Cooke TG; McArdle CS
    Gut; 1993 Apr; 34(4):554-7. PubMed ID: 8491406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.